heapsreal
iherb 10% discount code OPA989,
- Messages
- 10,218
- Location
- australia (brisbane)
WHo's this Leonard jason guy, he seems to know what he's talking about. Good to hear someone like him talking.
If he wants to leave XMRV behind, why is he doing a study? In this case the only reason for doing that study could be to disprove the association between XMRV and ME/CFS. Should you really do a study, if you're not objective?
By the way are we really sure that the WPI is participating in this study? I think that was the "Maldarelli" study he was talking about there.
What the ... is wrong with this guy Coffin?? He seriously said "We should leave this virus that we know as XMRV behind"... I can't believe what i just heard. It's true that it could just be a contaminant, even though i don't find that possibility likely, but how could anyone of his intelligence say this? If there's the possibility that this virus could be in the population and the blood supply and causing a number of diseases including cancers??? Before it's proven that there was contamination i think "leaving XMRV behind" and just hoping it will go away if you don't look at it is beyond negligent...
Maybe he seems a bit "strange" beacuse he was having a cold (i think i read that).
But when i look at this video http://www.youtube.com/user/vikwalk#p/u/2/b-1K7i4Sjvs, i will make it official and say i don't trust him. Maybe that's not a smart thing to say and i had a pretty hard day because i was in the coach for hours, but that's the feeling i get when i see him speak there. And he should not be so aggressive. He is acting like someone who thinks when he says it's over, it's over. Sorry John, but that's not the case.
There's a reason they want this event to have a date attached to it. It's to protect someone's liability. Mislead, confuse the facts and hope XMRV just goes away. I'm afraid it was a little too obvious. I absolutely could not stand the disdain that Coffin showed towards Mitkovis. He talked over her and refused to let her speak much at all. I sure hope the real truth will stand up some day.
I thought he made some compelling arguments against XMRV.i think coffin is backed into a corner with people around him alot more knowledgable then he will ever be on the subject. he was poopin his pants, lol, with mass hysteria!!
My comments come from the fact that he states contamination and when klimas said to him if contamination was a problem wouldnt the healthy controls have a high level of xmrv too. He dribbled off on a different tangent.Huh?? How are people coming to these conclusions, I sometimes feel like I am on another planet. His reason to mislead and confuse the facts about XMRV in hopes that it would go away would be for what? He started studying it for the same reason everyone else started studying it because it sparked his interest, not to setup a super secrete government conspiracy to keep CFS patients sick. This has gotten so ridiculous that he had to make a comment about it. http://www.youtube.com/watch?v=b-1K7i4Sjvs
I thought he made some compelling arguments against XMRV.
My comments come from the fact that he states contamination and when klimas said to him if contamination was a problem wouldnt the healthy controls have a high level of xmrv too. He dribbled off on a different tangent.
i rest my case.
but there are others who have replicated the studies. Even in germany they found it in respiratory droplets, i dont know if this particular study has been replicated but it shows how others are finding it. It also depends on the type of patients they are picking, are they picking patients who just have depression as thats what alot of the CDC think cfs is. I think they should pick patients with poor nk function and other immune abnormalities, nk function is a common one, so i dont know why this isnt used as well.
My main concern with XMRV is that a large majority of scientist can not replicate the WPI findings....
the arguments for contamination make valid points that must be taken seriously
DAY 2 FRIDAY, APRIL 8
7:00 8:00 a.m. REGISTRATION
8:00 8:15 a.m. RECONVENE
DIAGNOSIS AND BIOMARKERS
NIH Moderator: Donald G. Blair, Ph.D., National Cancer Institute, NIH
Co-Moderator: Samir Khleif, M.D., National Cancer Institute, NIH
8:15 8:35 a.m. Nancy Klimas, M.D., University of Miami, Miller School of Medicine
Immune Based Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
8:35 8:55 a.m. Dane B. Cook, Ph.D., University of Wisconsin, Madison
Can Functional Neuroimaging Data Serve as a Biomarker for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
8:55 9:15 a.m. Michael Dean, Ph.D., National Cancer Institute, NIH
Identifying Genes and Genetic Risk Factors for Complex Diseases
9:15 9:35 a.m. Summary and Panel Discussion
TREATMENT
NIH Moderator: Christopher Mullins, Ph.D., National Institute of Diabetes and Digestive and Kidney Diseases, NIH
Co-Moderator: Susan Keay, M.D., Ph.D., University of Maryland School of Medicine; and Veterans Administration Maryland Health Care System
9:35 9:40 a.m. Session Overview
9:40 10:00 a.m. Fred Friedberg, Ph.D., State University of New York, Stony Brook
Self-Management in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and the Meaning of "Improvement"
10:00 10:20 a.m. Italo Biaggioni, M.D., Vanderbilt University
Chronic Fatigue and Postural Tachycardia Syndromes
10:20 10:35 a.m. MORNING BREAK
10:35 10:55 a.m. Theoharis C. Theoharides, M.D., Ph.D., M.S., F.A.A.A.A.I., Tufts University School of Medicine Substance P-Stimulated TNF Secretion from Human Mast Cells Involves Fission and Translocation of Mitochondria with Extracellular DNA Release That Induces Auto-Inflammation, Processes Blocked by the Natural Flavonoid Luteolin
10:55 11:15 a.m. Lucinda Bateman, M.D., Fatigue Consultation Clinic, Salt Lake City
Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome at the Fatigue Consultation Clinic: The Art of Supportive Care Medicine
11:15 11:45 a.m. Summary and Panel Discussion
11:45 a.m. 1:00 p.m. LUNCH
OPPORTUNITIES FOR COMMUNICATION (A Panel Discussion)
NIH Moderators: John T. Burklow and Marin P. Allen, Ph.D., Office of Communications and Public Liaison, NIH
1:00 1:05 p.m. Session Overview
1:05 1:15 p.m. K. Kimberly McCleary, CFIDS Association of America
Communicating with Research Stakeholders
1:15 1:25 p.m. Kenneth J. Friedman, Ph.D., Castleton State College
Elephants in the Room: Acknowledging Impediments to Chronic Fatigue Syndrome Research and Education
1:25 1:40 p.m. Patricia Fero, M.E.P.D., Wisconsin ME/CFS Association, Inc.
3 Generations: A View from Wisconsin
Mary M. Schweitzer, Ph.D., MCEAS, University of Pennsylvania
The Role for Internet in Communication
1:40 1:50 p.m. John T. Burklow, Office of Communications and Public Liaison, NIH
1:50 2:15 p.m. Summary and Panel Discussion
2:15 2:30 p.m. AFTERNOON BREAK
SUMMARY
NIH Moderator: Dennis Mangan, Ph.D., Office of Research on Women's Health, NIH
Co-Moderator: Suzanne D. Vernon, Ph.D., CFIDS Association of America
2:30 4:45 p.m. All Speakers and Co-Moderators
Summary of Each Session
Responses by Department of Health and Human Services Federal Agencies
Full Workshop Panel Discussion
4:45 5:00 p.m. CLOSING COMMENTS
Vivian W. Pinn, M.D., Office of Research on Women's Health, NIH